These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6897834)

  • 1. Production of antisera to des Asn28 Thr29 Homoser27-glucagon; the development of radioimmunoassay for total glucagon-like immunoreactivity in human plasma.
    Nishino T; Kodaira T; Shin S; Imagawa K; Yanaihara N; Shima K; Kumahara Y
    Endocrinol Jpn; 1981 Aug; 28(4):419-27. PubMed ID: 6897834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of anti-glucagon sera with a C-terminal fragment of pancreatic glucagon.
    Imagawa K; Nishino T; Shin S; Uehata S; Hashimura E; Yanaihara C; Yanaihara N
    Endocrinol Jpn; 1979 Feb; 26(1):123-31. PubMed ID: 86440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of amidated forms of GLP-1 in rat tissues using a highly sensitive radioimmunoassay.
    van Delft J; Uttenthal LO; Hermida OG; Fontela T; Ghiglione M
    Regul Pept; 1997 Jun; 70(2-3):191-8. PubMed ID: 9272633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepancy of fasting plasma glucagon levels measured by different glucagon antisera.
    Tahara Y; Tanaka A; Yamamoto Y; Fukuda M; Kumahara Y; Shima K
    Diabetes Res; 1988 Apr; 7(4):179-83. PubMed ID: 3402167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of phenformin on the response of plasma intestinal glucagon-like immunoreactivity (GLI) to oral glucose in gastrectomized subjects.
    Shima K; Sawazaki N; Morishita S; Tarui S; Nishikawa M
    Proc Soc Exp Biol Med; 1975 Oct; 150(1):232-6. PubMed ID: 1187699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Big plasma glucagon in patients with liver cirrhosis. The discrepancy in values of immunoreactive glucagon measured by use of two different antisera against pancreatic glucagon, 30K and OAL-123].
    Tsubouchi H; Kamibeppu A; Fujisaki K; Oka H; Miyazaki H; Hirono S; Hashimoto S; Nagahama J; Gohda E; Daikuhara Y
    Nihon Shokakibyo Gakkai Zasshi; 1984 May; 81(5):1208-13. PubMed ID: 6471533
    [No Abstract]   [Full Text] [Related]  

  • 7. Production of a specific antiserum by synthetic C-terminal fragment of glucagon.
    Ohneda A; Watanabe K; Wakimatsu M; Fujino M
    Horm Metab Res; 1979 Aug; 11(8):463-8. PubMed ID: 574120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoglobulin G can cross-react with glucagon antisera and cause a spuriously high plasma immunoreactive glucagon level.
    Hattori N; Saiki Y; Kajikawa M; Ishihara T; Moridera K; Hino M; Ikekubo K; Kurahachi H
    Endocr J; 1995 Aug; 42(4):455-60. PubMed ID: 8556050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucagon radioimmunoassay with use of antiserum to glucagon C-terminal fragment.
    Nishino T; Kodaira T; Shin S; Imagawa K; Shima K; Kumahara Y; Yanaihara C; Yanaihara N
    Clin Chem; 1981 Oct; 27(10):1690-7. PubMed ID: 6169468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Radioligand assay: method and application. II. Effect of glucagon coupling on the production of glucagon antisera with suitable binding parameters for radioimmunoassay].
    Ziegler M; Keilacker H; Woltanski KP; Besch W; Schubert J
    Acta Biol Med Ger; 1980; 39(2-3):305-14. PubMed ID: 6775484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of plasma glucagon-like immunoreactivity (GLI) in patients with liver cirrhosis.
    Watanabe A; Hashimoto M; Higashi T; Kobayashi M; Nakatsukasa H; Yamauchi Y; Watanabe M; Fujiwara M; Nagashima H
    J Med; 1986; 17(2):95-108. PubMed ID: 3473162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of response of gut GLI to fat ingestion in dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Dec; 16 Suppl 1():105-9. PubMed ID: 6398248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of intestinal glucagon-like immunoreactivity (GLI) secretion by somatostatin in man.
    Marco J; Hedo JA; Villaneuva ML
    J Clin Endocrinol Metab; 1977 Apr; 44(4):695-8. PubMed ID: 849979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation of antiglucagon antibodies in rabbits and guinea pigs using a glucagon-carbodiimide-albumin conjugate.
    Flatt PR; Swanston-Flatt SK
    Endocrinol Exp; 1981; 15(1):3-16. PubMed ID: 6971218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of total pancreatectomy on the secretion of gut glucagon in humans.
    Yasui K
    Jpn J Surg; 1983 Mar; 13(2):122-9. PubMed ID: 6350663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of insulin on the response of gut glucagon-like immunoreactivity (GLI) to oral glucose and food ingestion in the goose.
    Karmann H; Mialhe P
    Horm Metab Res; 1987 Feb; 19(2):47-52. PubMed ID: 3549502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and characterization of an antiserum against pancreatic glucagon.
    Von Schenck H
    Clin Chim Acta; 1977 Nov; 80(3):455-63. PubMed ID: 912916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal metabolism of gut glucagon-like immunoreactivity.
    Rovira A; López-Novoa JM; Zubiaur M; Matesanz R; Ghiglione M; Pascual JM; Valverde I
    Endocrinology; 1982 Jun; 110(6):2030-6. PubMed ID: 6896180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2).
    Orskov C; Holst JJ
    Scand J Clin Lab Invest; 1987 Apr; 47(2):165-74. PubMed ID: 3576119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of oxyntomodulin and glucagon in the gastrointestinal tract and the plasma of the rat.
    Kervran A; Blache P; Bataille D
    Endocrinology; 1987 Aug; 121(2):704-13. PubMed ID: 3595539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.